Read this story here
Human Medications, Human Drugs, Animal Medications, Animal Drugs, Pharmacy law, Pharmaceutical law, Compounding law, Sterile and Non Sterile Compounding 797 Compliance, Veterinary law, Veterinary Compounding Law; Health Care; Awareness of all Types of Compounding Issues; Pharmacy Benefit Managers (PBMs), Outsourcing Facilities Food and Drug Administration and Compliance Issues
Showing posts with label Synthetic Drug Law. Show all posts
Showing posts with label Synthetic Drug Law. Show all posts
Thursday, February 21, 2013
Tuesday, January 29, 2013
Bill would ban basic compounds behind synthetic drugs like bath salts, spice
Tuesday, Jan. 29, 2013By MATTHEW LONGDON
Cronkite News
Cronkite News
About HB 2327:
• Author: Rep. Eddie Farnsworth, R-Gilbert.
• Key provision: Would expand the state's definition of dangerous drugs to include chemical configurations that typically compose synthetic cannabinoids and bath salts.
• Status: Endorsed by the House Judiciary Committee and headed to the floor by way of the Rules Committee.
PHOENIX – It’s become a pattern as state lawmakers try to address synthetic drugs such as bath salts or spice: Almost as soon as one recipe is outlawed, manufacturers simply change to a mix that isn’t banned.
Hoping to get ahead of that cycle, the chairman of the House Judiciary Committee is out to ban the basic chemical formulas underlying such drugs.
“Imagine a Christmas tree. You can change one of the bulbs on the lights and it’s a little different, but it’s the same tree,” said Rep. Eddie Farnsworth, R-Gilbert. “This bill would just outlaw the Christmas tree.”
Farnsworth said that chemists have identified the most basic formulas used to create synthetic drugs. HB 2327 would ban those basic formulas so the substances are always illegal despite any alteration.
He said he avoided banning any formula that had a legitimate commercial use, such as the recipes for cleaning supplies.
Continue to read here
Sunday, January 27, 2013
Indiana Board of Pharmacy Rule Change
Synthetic Drug Emergency Rules
Synthetic Drug Emergency Rules
Indiana Code 25-26-13-4.1 gives the Indiana Board of Pharmacy the authority to adopt emergency rules declaring a substance to be a synthetic drug if the substance has been scheduled or emergency scheduled by the DEA or scheduled, emergency scheduled, or criminalized by another state.
Controlled substances listed in IC 35-48-2-4 are included in Schedule I. “Synthetic drugs,” as defined in IC 35-31.5-2-321, are listed as Schedule I drugs under IC 35-48-2-4(d)(35). Indiana Code 35-31.5-2-321(9) includes in the definition of synthetic drug “any compound determined to be a synthetic drug by rule adopted under IC 25-26-13-4.1.”
The Indiana Board of Pharmacy has promulgated the following emergency rules in accordance with IC 35-26-13-4.1:
LSA #12-493(E)
Indiana Code 25-26-13-4.1 gives the Indiana Board of Pharmacy the authority to adopt emergency rules declaring a substance to be a synthetic drug if the substance has been scheduled or emergency scheduled by the DEA or scheduled, emergency scheduled, or criminalized by another state.
Controlled substances listed in IC 35-48-2-4 are included in Schedule I. “Synthetic drugs,” as defined in IC 35-31.5-2-321, are listed as Schedule I drugs under IC 35-48-2-4(d)(35). Indiana Code 35-31.5-2-321(9) includes in the definition of synthetic drug “any compound determined to be a synthetic drug by rule adopted under IC 25-26-13-4.1.”
The Indiana Board of Pharmacy has promulgated the following emergency rules in accordance with IC 35-26-13-4.1:
LSA #12-493(E)
Thursday, July 12, 2012
President Obama Signs First Federal Synthetic Drug Law
Wednesday, 11 July 2012 13:46 | Author: The Times Weekly |
President Obama has signed The Synthetic Drug Abuse Prevention Act of 2012 - law, which will add 26 chemicals to the Schedule I list of the Controlled Substances Act; extend the executive authority of the DEA over synthetic drugs to three years; and criminalize the manufacture, distribution, sale, and use of certain synthetic drugs-including a minimum 20 year sentence for those who are directly responsible for the death or injury of another person by manufacturing, distribution or sales of synthetic drugs.
Previously, under the DEA Temporary Ban, the DEA had the power to ban new and emerging drugs if they and the U.S. Department of Health and Human Services could demonstrate within 18 months that the drug was harmful and lacked medicinal or industrial value. The new law will allow and additional 18 months so that the DEA can conduct the complex requisite research and scientific analysis to support a final scheduling determination.
To read remainder of article, click here.
Subscribe to:
Posts (Atom)